Araneo B A, Woods M L, Daynes R A
Department of Pathology, University of Utah School of Medicine, Salt Lake City.
J Infect Dis. 1993 Apr;167(4):830-40. doi: 10.1093/infdis/167.4.830.
This study sought to establish whether administration of dehydroepiandrosterone (DHEA) or its sulfate derivative to aged mice could effectively correct the immunosenescent phenotype. Supplemental DHEA sulfate and topical DHEA fully corrected the age-associated dysregulated production of T cell lymphokines by cells from all of the different lymphoid organs tested. Either DHEA or DHEA sulfate supplementation promoted enhanced antibody responses against recombinant hepatitis B surface antigen (rHBsAg) by the aged recipients when incorporated directly into the vaccine. When DHEA was provided either topically or was incorporated directly into vaccine, vigorous primary and secondary antibody responses were detected in the aged mice given a single administration of DHEA, regardless of the mode of administration. It was also established that DHEA treatment could enhance specific antibody responses to rHBsAg in aged animals that had previously not been effectively immunized by conventional vaccination procedures.
本研究旨在确定给衰老小鼠施用脱氢表雄酮(DHEA)或其硫酸盐衍生物是否能有效纠正免疫衰老表型。补充硫酸脱氢表雄酮和局部施用脱氢表雄酮完全纠正了来自所有测试的不同淋巴器官的细胞与年龄相关的T细胞淋巴因子产生失调。当直接将DHEA或硫酸脱氢表雄酮掺入疫苗中时,补充这两种物质均可促进衰老受体对重组乙型肝炎表面抗原(rHBsAg)的抗体反应增强。当局部施用DHEA或将其直接掺入疫苗中时,单次施用DHEA的衰老小鼠均检测到强烈的初次和二次抗体反应,而与施用方式无关。还证实,DHEA治疗可增强先前未通过传统疫苗接种程序有效免疫的衰老动物对rHBsAg的特异性抗体反应。